 SAN CARLOS, Calif., July 15, 2021 GLOBE NEWSWIRE -- BioCardia, Inc. Nasdaq: BCDA, a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases today announces that the Japan Patent Office has granted Patent No: 6887216 titled, Target Site Selection, Entry, and Update With Automatic Remote Image Annotation with a patent term that will expire on January 8, 2034. 